Onesource Specialty Pharma Limited has informed the Exchange about Transcript of the Earnings Call

Onesource Specialty Pharma Limited has submitted the transcript of its recent earnings call to NSE as a regulatory filing. This is a routine disclosure required after the company's quarterly or annual results call with analysts and investors. The transcript would contain management's discussion of financial performance, business outlook, and responses to analyst questions. Investors interested in detailed management commentary can access the full transcript through the NSE filings section.